Healthcare | April 20, 2026
MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
The launch coincides with IBS Awareness Month in April
The launch coincides with IBS Awareness Month in April
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
Subscribe To Our Newsletter & Stay Updated
